Early research (Phase 1)Study completedNCT01144936What this trial is testingStudy of VX-985 in Subjects With Chronic Hepatitis CWho this might be right forChronic Hepatitis C Vertex Pharmaceuticals Incorporated 21
Post-approval studies (Phase 4)Study completedNCT00629967What this trial is testingTrial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 PatientsWho this might be right forChronic Hepatitis CGenotype Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Large-scale testing (Phase 3)Study completedNCT02600325What this trial is testingDutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCVWho this might be right forAcute Hepatitis CHuman Immunodeficiency VirusHepatitis C Erasmus Medical Center 80
Large-scale testing (Phase 3)Study completedNCT01854697What this trial is testingEvaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment BeforeWho this might be right forChronic Hepatitis C Infection AbbVie 311
Testing effectiveness (Phase 2)Study completedNCT01180790What this trial is testingSafety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive ParticipantsWho this might be right forHepatitis C Alexion Pharmaceuticals, Inc. 122
Post-approval studies (Phase 4)Study completedNCT00353418What this trial is testingPEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infectionWho this might be right forHepatitis C, Chronic Hoffmann-La Roche 415
Testing effectiveness (Phase 2)Study completedNCT01987453What this trial is testingLedipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment StudyWho this might be right forHCV Infection Gilead Sciences 100
Testing effectiveness (Phase 2)Study completedNCT00987337What this trial is testingFilibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 SubjectsWho this might be right forHepatitisHepatitis C Pfizer 288
Large-scale testing (Phase 3)Study completedNCT03833362What this trial is testingEfficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)Who this might be right forHepatitis C R-Pharm 420
Not applicableStudy completedNCT02725866What this trial is testingReal World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis CWho this might be right forChronic Hepatitis C AbbVie 216
Large-scale testing (Phase 3)Study completedNCT01292239What this trial is testingA Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected PatientsWho this might be right forHepatitis C, Chronic Janssen Pharmaceutical K.K. 183
Post-approval studies (Phase 4)UnknownNCT02950870What this trial is testingEfficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.Who this might be right forChronic Hepatitis, C Virus University of Modena and Reggio Emilia 75
Large-scale testing (Phase 3)Ended earlyNCT00423800What this trial is testingEfficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 56
Not applicableStudy completedNCT00863109What this trial is testingQuality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)Who this might be right forHepatitis C, ChronicGenotype 1HCV-1 Merck Sharp & Dohme LLC 133
Not applicableStudy completedNCT02669940What this trial is testingObservational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian FederationWho this might be right forChronic Hepatitis CGenotype 1 AbbVie 158
Testing effectiveness (Phase 2)Study completedNCT03593447What this trial is testingTo Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected PatientsWho this might be right forChronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Testing effectiveness (Phase 2)Study completedNCT01271790What this trial is testingResponse-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CWho this might be right forHepatitis C, Chronic Gilead Sciences 245
Testing effectiveness (Phase 2)Study completedNCT00726882What this trial is testingA Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 StudiesWho this might be right forHCV Infection AbbVie (prior sponsor, Abbott) 35
Not applicableStudy completedNCT02508090What this trial is testingLong-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus RibavirinWho this might be right forChronic Hepatitis C Hoffmann-La Roche 10
Testing effectiveness (Phase 2)Study completedNCT00944684What this trial is testingHigh Dose Ribavirin in the Treatment of Chronic Hepatitis CWho this might be right forChronic Hepatitis C University of Bern 32